Skip to main content
. Author manuscript; available in PMC: 2024 Aug 1.
Published in final edited form as: Hepatology. 2023 Feb 22;78(2):578–591. doi: 10.1097/HEP.0000000000000313

Figure 1.

Figure 1.

Figure 1.

Figure 1.

Prevalence of fatty liver disease (CAP ≥ 263 dB/m), clinically significant and advanced fibrosis in person with HIV

A. The entire cohort

B. Clinically significant and advanced fibrosis in participants with fatty liver

C. Clinically significant and advanced fibrosis in participants with NAFLD